# Conforma Therapeutics Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/conforma-therapeutics

- Industry: Biotechnology
- Headquarters: San Diego, US
- Total disclosed funding: $41M
- Latest round: Series C (May 3, 2005)
- Investors on record: 9

## About

Conforma Therapeutics Corporation is a bio-pharmaceutical company focused on the design and development of novel drugs for the treatment of cancer.

## Funding rounds

- Series C, May 3, 2005, $11M — Domain Associates, Forward Ventures, RBC Capital Markets, Lilly Ventures, RiverVest Ventures Partners, Mesa Verde Venture Partners, SR One, ProQuest Investments, Novo Holdings A/S
- Series C, Sep 18, 2003, $30M — Domain Associates, Forward Ventures, RBC Capital Markets, Lilly Ventures, RiverVest Ventures Partners, Mesa Verde Venture Partners, SR One, ProQuest Investments, Novo Holdings A/S

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series C
- Forward Ventures (https://capitalatlas.ai/funds/forward-ventures) — Series C
- RBC Capital Markets (https://capitalatlas.ai/funds/rbc-capital-markets) — Series C
- Lilly Ventures (https://capitalatlas.ai/funds/lilly-ventures) — Series C
- RiverVest Ventures Partners (https://capitalatlas.ai/funds/rivervest-ventures-partners) — Series C
- Mesa Verde Venture Partners (https://capitalatlas.ai/funds/mesa-verde-venture-partners) — Series C
- SR One (https://capitalatlas.ai/funds/sr-one) — Series C
- ProQuest Investments (https://capitalatlas.ai/funds/proquest-investments) — Series C
- Novo Holdings A/S — Series C